| Q33912242 | 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex |
| Q48594004 | 5-HT1A receptor agonist properties of the antipsychotic, nemonapride: comparison with bromerguride and clozapine |
| Q44543846 | 5-Hydroxytryptamine 1A receptors inhibit cold-induced sympathetically mediated cutaneous vasoconstriction in rabbits. |
| Q45052989 | A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment |
| Q34473925 | Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study |
| Q61713932 | Agonist-stimulated GTPγ[35S] binding to 5-HT1A receptors in human post-mortem brain |
| Q44675329 | Aripiprazole (OPC-14597) fully substitutes for the 5-HT1A receptor agonist LY293284 in the drug discrimination assay in rats |
| Q39271592 | Clozapine effects on adenylyl cyclase activity and serotonin type 1A receptors in human brain post-mortem |
| Q50641778 | Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia. |
| Q44552460 | Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924. |
| Q48474976 | Distribution of Fos- and Jun-related proteins and activator protein-1 composite factors in mouse brain induced by neuroleptics |
| Q42667527 | Dopamine D4 receptor and anxiety: behavioural profiles of clozapine, L-745,870 and L-741,742 in the mouse plus-maze |
| Q47755439 | Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens |
| Q40646758 | Effects of clozapine on sleep: a longitudinal study |
| Q48345571 | Modification of haloperidol-induced pattern of c-fos expression by serotonin agonists |
| Q40932666 | Neurotransmitter systems in schizophrenia. |
| Q40524584 | New approaches to the drug treatment of schizophrenia |
| Q55068023 | Novel mutations in the promoter and coding region of the human 5-HT1A receptor gene and association analysis in schizophrenia. |
| Q41428568 | Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. |
| Q44602755 | Serotonin 5-HT1A receptors might control the output of cortical glutamatergic neurons in rat cingulate cortex |
| Q38777651 | Sleep quality in schizophrenia and the effects of atypical antipsychotic medication |
| Q44454999 | The 5-HT1A receptor agonist MKC-242 reverses isolation rearing-induced deficits of prepulse inhibition in mice |
| Q33845251 | The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? |
| Q33762791 | The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics? |
| Q43601443 | The effect of tandospirone, a serotonin(1A) agonist, on memory function in schizophrenia |